Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05067283 |
|---|---|
| Brief Title: | A Study of MK-1084 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Advanced Solid Tumors (MK-1084-001) |
| First Submitted : | October 1, 2021 |
| First Submitted that Met QC Criteria : | October 1, 2021 |
| First Posted : | October 5, 2021 |
| Last Update Submitted that Met QC Criteria : | June 6, 2023 |
| Last Update Posted : | June 7, 2023 |